JUM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hobbins, J. C.
Right arrow Articles by Abuhamad, A. Z.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hobbins, J. C.
Right arrow Articles by Abuhamad, A. Z.
© 2003 by the American Institute of Ultrasound in Medicine
J Ultrasound Med 22:33-38 • 0278-4297

An 8-Center Study to Evaluate the Utility of Midterm Genetic Sonograms Among High-Risk Pregnancies

John C. Hobbins, MD, Dennis C. Lezotte, PhD, Wayne H. Persutte, BS, RDMS, Greggory R. DeVore, MD, Beryl R. Benacerraf, MD, David A. Nyberg, MD, Anthony M. Vintzileos, MD, Lawrence D. Platt, MD, Dru E. Carlson, MD, Raymond O. Bahado-Singh, MD and Alfred Z. Abuhamad, MD

Departments of Obstetrics and Gynecology and Preventive Medicine and Biostatistics, University of Colorado School of Medicine, Denver, Colorado (J.C.H., D.C.L., W.H.P.); Fetal Diagnostic Center of Pasadena and Alfigen, Genetics Institute, Pasadena, California (G.D.); Department of Obstetrics and Gynecology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts (B.R.B.); Pacific Northwest Diagnostic Ultrasound and University of Washington School of Medicine, Seattle, Washington (D.A.N.); Department of Maternal-Fetal Medicine and Obstetrics, University of Medicine and Dentistry of New Jersey, New Brunswick, New Jersey (A.M.V.); Department of Obstetrics and Gynecology, Cedars-Sinai Medical Center, University of California Los Angeles School of Medicine, Los Angeles, California (L.D.P., D.C.); Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, Yale University School of Medicine, New Haven, Connecticut (R.O.B.-S.); and Division of Maternal-Fetal Medicine, Eastern Virginia Medical School, Norfolk, Virginia (A.Z.A.) USA.

Address correspondence and reprint requests to John C. Hobbins, MD, Department of Obstetrics and Gynecology, University of Colorado Health Sciences Center, 4200 E Ninth Ave, Mail Stop B198, Denver, CO 80262 USA.

Objective. A multicenter study was undertaken to evaluate the diagnostic efficacy of a genetic sonogram. Methods. Eight centers provided data on 176 pregnancies complicated by fetal Down syndrome. One hundred thirty-four pregnancies were considered high risk because of advanced maternal age (>35 years), and 42 were considered high risk for having "abnormal" triple-screen results (risk >1:250). Each center provided fetal biometric data, information regarding the presence or absence of major structural abnormalities, and between 3 and 6 additional ultrasonographic markers for trisomy 21. The heterogeneity of our 8 independent "sensitivity estimates" was evaluated by Poisson regression, and a single combined estimate of the sensitivity was calculated. Results. Of the total 176 cases of trisomy 21, 125 fetuses (71.0%) had either an abnormal long bone length (femur length, humerus length, or both), a major structural abnormality, or a Down syndrome marker. The combined diagnostic sensitivity was 71.6%, with a range of 63.6% (7 of 11) to 80% (8 of 10). Five centers had sensitivity estimates falling between 64% and 76%. The sensitivity of individual markers varied between 3% (sandal gap) and 46.5% (nuchal skin fold thickness). A condensed regimen of nuchal skin fold thickness, femur length, and a standard anatomic survey would screen in 56.8% of fetuses with Down syndrome. Conclusions. This 8-center study that included many fetuses with Down syndrome validates the concept that the genetic sonogram can be used to better adjust the Down syndrome risk for high-risk patients.

Key Words: Down syndrome • prenatal diagnosis • second trimester • ultrasonography

Abbreviations: AMA, advanced maternal age • EIF, echogenic intracardiac focus • MSTS, maternal serum triple-screen • NSFT, nuchal skin fold thickness




This article has been cited by other articles:


Home page
 Obstet GynecolHome page
U. M. Reddy, R. A. Filly, and J. A. Copel
Prenatal Imaging: Ultrasonography and Magnetic Resonance Imaging
Obstet. Gynecol., July 1, 2008; 112(1): 145 - 157.
[Abstract] [Full Text] [PDF]

Home page
 Obstet GynecolHome page
B. Weisz, P. P. Pandya, A. L. David, W. Huttly, P. Jones, and C. H. Rodeck
Ultrasound Findings After Screening for Down Syndrome Using the Integrated Test
Obstet. Gynecol., May 1, 2007; 109(5): 1046 - 1052.
[Abstract] [Full Text] [PDF]

Home page
 Obstet GynecolHome page
J. Cleary-Goldman, M. A. Morgan, F. D. Malone, J. N. Robinson, M. E. D'Alton, and J. Schulkin
Screening for Down Syndrome: Practice Patterns and Knowledge of Obstetricians and Gynecologists
Obstet. Gynecol., January 1, 2006; 107(1): 11 - 17.
[Abstract] [Full Text] [PDF]

Home page
 J Ultrasound MedHome page
L. T. Tran, D. B. Carr, L. M. Mitsumori, S. B. Uhrich, and L. E. Shields
Second-Trimester Biparietal Diameter/Nasal Bone Length Ratio Is an Independent Predictor of Trisomy 21
J. Ultrasound Med., June 1, 2005; 24(6): 805 - 810.
[Abstract] [Full Text] [PDF]

Home page
 Obstet GynecolHome page
L. D. Platt, N. Greene, A. Johnson, J. Zachary, E. Thom, D. Krantz, J. L. Simpson, R. K. Silver, R. J. M. Snijders, L. Goetzl, et al.
Sequential Pathways of Testing After First-Trimester Screening for Trisomy 21
Obstet. Gynecol., October 1, 2004; 104(4): 661 - 666.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American Institute of Ultrasound in Medicine.